Transplant Infectious Disease
Author:
Keywords:
Science & Technology, Life Sciences & Biomedicine, Immunology, Infectious Diseases, Transplantation, invasive fungal disease, lomentosporiosis, scedosporiosis, solid organ transplantation, RESPIRATORY-TRACT SPECIMENS, CYSTIC-FIBROSIS PATIENT, ANTIFUNGAL PROPHYLAXIS, APIOSPERMUM INFECTION, CLINICAL-SIGNIFICANCE, AIRWAY COLONIZATION, MOLD INFECTIONS, AORTIC-ANEURYSM, SPUTUM SAMPLES, VORICONAZOLE, Ascomycota, Disease Management, Humans, Immunocompromised Host, Internationality, Lung Transplantation, Mycoses, Prospective Studies, Respiratory Tract Infections, Scedosporium, Surveys and Questionnaires, SCEDO-LUNG collaborative group, 1103 Clinical Sciences, Surgery, 3202 Clinical sciences
Abstract:
BACKGROUND: Scedosporium species and Lomentospora prolificans (S/L) are the second most common causes of invasive mold infections following Aspergillus in lung transplant recipients. METHODS: We assessed the current practices on management of S/L colonization/infection of the lower respiratory tract before and after lung transplantation in a large number of lung transplant centers through an international practice survey from October 2016 to March 2017. RESULTS: A total of 51 respondents from 45 lung transplant centers (17 countries, 4 continents) answered the survey (response rate 58%). S/L colonization was estimated to be detected in candidates by 48% of centers. Only 18% of the centers used a specific medium to detect S/L colonization. Scedosporium spp. colonization was a contraindication to transplantation in 10% of centers whereas L prolificans was a contraindication in 31%; 22% of centers declared having had 1-5 recipients infected with S/L in the past 5 years. CONCLUSIONS: This survey gives an overview of the current practices regarding S/L colonization and infection in lung transplant centers worldwide and underscores the need of S/L culture procedure standardization before implementing prospective studies.